Who is sponsoring NCT04465201?

NCT04465201 is sponsored by Abiomed Inc..

What drugs are being tested in NCT04465201?

Interventions in NCT04465201: Impella CP with Smart Assist (Circulatory Support System).

What condition does NCT04465201 study?

NCT04465201 studies Cardiac Output.

Is NCT04465201 still recruiting?

NCT04465201 is currently active, enrolled. Last updated 24 October 2022.

Last reviewed 2022-10-24 · How we verify

NCT04465201

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Smart Pump Study

Active, enrolled NA Last updated 24 October 2022

What this trial tests

NA trial testing Impella CP with Smart Assist (Circulatory Support System) in Cardiac Output in 35 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 November 2020

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Abiomed Inc.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	2 November 2020
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	6 locations across United States

Drugs / interventions tested

Impella CP with Smart Assist (Circulatory Support System)

Conditions studied

Cardiac Output — all drugs for Cardiac Output →

Sponsor

Abiomed Inc. — full company profile →

Who can join

18 and older, any sex, with Cardiac Output. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To demonstrate that the Impella® Hemodynamic Platform (the "Study Device") is safe, and measurements obtained are as good as currently used methods. These measurements include how much pressure the heart is generating and how much blood your heart is pumping during the PCI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Output

Currently open trials in the same condition.

NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
NCT06551168 — Heat Acclimation in Females · NA · recruiting
NCT06879769 — Optimization of Patient Preparation and Imaging Techniques for Cardiac CT · NA · recruiting

Other Abiomed Inc. trials

Trials by the same sponsor.

NCT06965504 — INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for C · NA · not yet recruiting
NCT06765226 — Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps · recruiting
NCT06964685 — Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock · recruiting
NCT06308055 — Abiomed Impella RT-DAQ - Observational Study · active not recruiting
NCT06637644 — Impella RP Flex with Smart Assist · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04465201 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abiomed Inc.
Last refreshed: 24 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04465201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing